Susanna A. McColley, MD

Professor of Pediatrics
Northwestern University Feinberg School of Medicine

Poster(s):

• (22) Characteristics of Late Diagnosis Through Newborn Screening and Effects on Growth and Pulmonary Health Outcomes in Infants with CF
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (93) Developing Individualized State-Level Reports for the Evaluation of the CF Newborn Screening: From Specimen Collection to Follow-up Over 10 Years
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (162) The Acceptability and Usability of a Soft, Flexible, Wearable Device for Cough Detection in Pediatric Cystic Fibrosis Patients
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (163) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and ≥1 F508del allele: 96-week interim results from an open-label extension study
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (364) Detection of Disease-Causing CFTR Variants In State Newborn Screening Programs
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (693) A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 2 Through 5 Years of Age with Cystic Fibrosis and at Least One F508del Allele
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET